Mikael BJURSELL et al. Therapeutic CRISPR/Cas9 Genome Editing in a Humanized Mouse Model Ameliorates \(\alpha\)1-antitrypsin Deficiency Phenotype. Research Perspectives of Microbiology and Biotechnology Vol. 9, [S. l.], p. 14–31, 2025. DOI: 10.9734/bpi/rpmab/v9/3611. Disponível em: https://stm.bookpi.org/RPMAB-V9/article/view/16958. Acesso em: 4 jun. 2026.